Suchergebnisse - "Gödel, Philipp"

PubPharm (34)

1

Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation

enthalten in: European journal of haematology | 2024

von Kutsch, N. | Gödel, P. | Voltin, C. | +4

2

Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR

enthalten in: European journal of haematology | 2024

von Heger, J. | d'Hargues, Y. | Kleinert, F. | +16

3

Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapy

enthalten in: British journal of haematology | 2024

von Eichenauer, D. | Heger, J. | Kruschel, I. | +12

4

Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Voltin, C. | Paccagnella, A. | Winkelmann, M. | +26

5

An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL

enthalten in: Cell reports. Medicine | 2024

von Prinz, L. | Riet, T. | Neureuther, D. | +22

6

Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA

enthalten in: Blood | 2024

von Heger, J. | Mattlener, J. | Schneider, J. | +20

CommentIn: Blood. 2024 Feb 8;143(6):478-480. - PMID 38329774

7

Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR

enthalten in: European Journal of Haematology | 2024

von Heger, J. | d'Hargues, Y. | Kleinert, F. | +16

8

Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Voltin, C. | Paccagnella, A. | Winkelmann, M. | +26

9

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma : Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

enthalten in: HemaSphere | 2023

von Bücklein, V. | Perez, A. | Rejeski, K. | +24

ErratumIn: Hemasphere. 2023 Oct 31;7(11):e982. - PMID 37920708

10

Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2023

von Fan, J. | Adams, A. | Sieg, N. | +22